Literature DB >> 2219901

The eosinophilia-myalgia syndrome.

S A Jimenez, J Varga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2219901      PMCID： PMC1002546     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  9 in total

1.  Clinical spectrum of the systemic manifestations of the eosinophilia-myalgia syndrome.

Authors:  J Varga; T D Heiman-Patterson; D L Emery; R Griffin; E V Lally; J J Uitto; S A Jimenez
Journal:  Semin Arthritis Rheum       Date:  1990-06       Impact factor: 5.532

2.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  T A Medsger
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

3.  Association of the eosinophilia-myalgia syndrome with the ingestion of tryptophan.

Authors:  P A Hertzman; W L Blevins; J Mayer; B Greenfield; M Ting; G J Gleich
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

4.  Diffuse fasciitis with eosinophilia. A clinicopathologic study.

Authors:  H M Moutsopoulos; B L Webber; N A Pavlidis; G Fostiropoulos; D Goules; L E Shulman
Journal:  Am J Med       Date:  1980-05       Impact factor: 4.965

5.  Tryptophan-induced eosinophilia-myalgia syndrome.

Authors:  L A Criswell; K E Sack
Journal:  West J Med       Date:  1990-09

6.  Scleroderma, fasciitis, and eosinophilia associated with the ingestion of tryptophan.

Authors:  R M Silver; M P Heyes; J C Maize; B Quearry; M Vionnet-Fuasset; E M Sternberg
Journal:  N Engl J Med       Date:  1990-03-29       Impact factor: 91.245

Review 7.  NIH conference. The idiopathic hypereosinophilic syndrome. Clinical, pathophysiologic, and therapeutic considerations.

Authors:  A S Fauci; J B Harley; W C Roberts; V J Ferrans; H R Gralnick; B H Bjornson
Journal:  Ann Intern Med       Date:  1982-07       Impact factor: 25.391

8.  Development of diffuse fasciitis with eosinophilia during L-tryptophan treatment: demonstration of elevated type I collagen gene expression in affected tissues. A clinicopathologic study of four patients.

Authors:  J Varga; J Peltonen; J Uitto; S Jimenez
Journal:  Ann Intern Med       Date:  1990-03-01       Impact factor: 25.391

9.  Development of a scleroderma-like illness during therapy with L-5-hydroxytryptophan and carbidopa.

Authors:  E M Sternberg; M H Van Woert; S N Young; I Magnussen; H Baker; S Gauthier; C K Osterland
Journal:  N Engl J Med       Date:  1980-10-02       Impact factor: 91.245
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.